https://www.cochrane.org/fr/cd014785/behav_limpact-du-suivi-et-de-la-promotion-de-la-croissance-chez-les-enfants-de-moins-de-cinq-ans-dans-les 2023 United Kingdom review of literature french abstract Follow CDISC SEND Country Terminology growth Interim Study Report Generalized Growth Intermediate Mitosis-Karyorrhexis Index IPSS-R Risk Category Intermediate promoter regions, genetic Country Code income International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria
- Intermediate-Risk Group aftercare asthenia Poverty Every Five Years Antimicrobial Intermediate Susceptibility Result Offspring Promotion Growth child Netherlands child, nos Clinical Study Follow-up Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement Child Impact
--- https://pgtmsite.files.wordpress.com/2024/01/publicationcjhp_mars-avril2014.pdf 2014 Canada drug information Therapeutic therapeutics Treatment drug, nos Every Five Years cooperative behavior patient care planning insurance, pharmaceutical services quebec Pharmacologic Management Collaboration drug therapy academic medical centers Program central hospital, nos Study Coordinating Center Schedule disease management Scheduled